Clinical Evaluation Of Amruthadi Kashaya in the management of Sheethapitta,an active controlled clinical study

Dr Chithra Ramachandran1 个研究点分布在 1 个国家目标入组 30 人开始时间: 2023年5月8日最近更新: 2023年4月8日

试验速览

阶段: 1/2 期
状态: 尚未招募
发起方
入组人数: 30
试验地点: 1
主要终点: Varati Damshta Samsthana Shotha (Inflammation like an insect bite)

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

This study is a Open label Comparative Clinical trial toevaluate the efficacy of Amruthadi kashaya as an add on drugto Haridrakhandaand Sarshapathaila.

Subjects are allocated in to study and comparatorgroups respectively.Minimum of 30 patients diagnosed as suffering from Sheethapitta fulfillingthe inclusion criteria irrespective of sex & religion will be selectedfor the comparative study. A separate case sheet pro forma will be prepared& subjects will be examined.

They will be divided in to 2 equalGroups A and B, where Group A will be administered with Amruthadikashaya 50 ml twice daily before food along with Haridrakhanda6gm twice daily before food. In Group B, Haridrakhanda alonewill be administered in the dosage of 6gm twice daily before foodSarshapathaila willbe given for both groups for external application

SUBJECTIVE PARAMETER:

Lakshanasof Sheethapitta

Varati Damshta Samsthana Shotha(Inflammation like an insect bite)
Kandu(Severe itching)
Toda(Excessive pain like pricking)
Vidaha(Burning Sensation)
Sa utsanga Saraga Mandala(Red Patches)
Kshanikotpattivinash(Transient)

Associated symptoms if any:

Pipasa(excessive thirst)
Jvara(fever)
Chhardi(vomiting*)*
Vibandha(constipation)
Raktalochanata(reddish discoloration of the eyes)
Dehasada(tiredness of the body)

OBJECTIVE PARAMETER:

Urticaria activity score=Itch severity score + no of hives

研究设计

研究类型: Interventional
分配方式: Not Applicable
盲法: Open Label

入排标准

年龄范围: 18.00 Year(s) 至 60.00 Year(s)（—）
性别: All

入选标准

•Subjects with classical lakshana of Sheethapitta.
•Subjects of either sex & religion within the age group of 18 to 60 years will be included.
•Subjects who are not having angioedema.
•Chronic spontaneous urticaria with duration greater than 6 weeks.
•Episodic urticaria with duration greater than 6 weeks.
•Subjects who are not on steroid medications.

排除标准

•Subjects suffering from serious systemic disorders like uncontrolled diabetes mellitus, SLE, Sjogrenâ€™s syndrome, autoimmune thyroid diseases, respiratory tract infection
•Angio edema.
•Acute urticaria less than 6 weeks.
•Subjects who are on steroid medications.